[PDF][PDF] Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung

IM de Kleer, M Kool, MJW de Bruijn, M Willart… - Immunity, 2016 - cell.com
IM de Kleer, M Kool, MJW de Bruijn, M Willart, J Van Moorleghem, MJ Schuijs, M Plantinga…
Immunity, 2016cell.com
Allergic disease originates in early life and polymorphisms in interleukin-33 gene (IL33) and
IL1RL1, coding for IL-33R and decoy receptor sST2, confer allergy risk. Early life T helper 2
(Th2) cell skewing and allergy susceptibility are often seen as remnants of feto-maternal
symbiosis. Here we report that shortly after birth, innate lymphoid type 2 cells (ILC2s),
eosinophils, basophils, and mast cells spontaneously accumulated in developing lungs in
an IL-33-dependent manner. During the phase of postnatal lung alveolarization, house dust …
Summary
Allergic disease originates in early life and polymorphisms in interleukin-33 gene (IL33) and IL1RL1, coding for IL-33R and decoy receptor sST2, confer allergy risk. Early life T helper 2 (Th2) cell skewing and allergy susceptibility are often seen as remnants of feto-maternal symbiosis. Here we report that shortly after birth, innate lymphoid type 2 cells (ILC2s), eosinophils, basophils, and mast cells spontaneously accumulated in developing lungs in an IL-33-dependent manner. During the phase of postnatal lung alveolarization, house dust mite exposure further increased IL-33, which boosted cytokine production in ILC2s and activated CD11b+ dendritic cells (DCs). IL-33 suppressed IL-12p35 and induced OX40L in neonatal DCs, thus promoting Th2 cell skewing. Decoy sST2 had a strong preventive effect on asthma in the neonatal period, less so in adulthood. Thus, enhanced neonatal Th2 cell skewing to inhaled allergens results from postnatal hyperactivity of the IL-33 axis during a period of maximal lung remodeling.
cell.com